MyFinsight
Home
Blog
About
Cash and cash
equivalents
$17,756K
(-26.89%↓ Y/Y)
Prepaid expenses and
other current assets
$1,659K
(22.89%↑ Y/Y)
Restricted cash, current
$729K
Inventories
$207K
(-70.13%↓ Y/Y)
Accounts receivable, net
of allowance for...
$192K
(-62.50%↓ Y/Y)
Total current assets
$20,543K
(-23.47%↓ Y/Y)
Machinery and equipment,
net, and...
$6,004K
(44.71%↑ Y/Y)
Right-of-use operating and
financing lease assets,...
$2,097K
Other noncurrent
assets
$556K
(-20.80%↓ Y/Y)
Restricted cash,
noncurrent
$243K
(-85.71%↓ Y/Y)
Total assets
$29,443K
(-41.72%↓ Y/Y)
Accumulated deficit
-$416,311K
(-13.45%↓ Y/Y)
Total liabilities and
shareholders' deficit
$29,443K
(-41.72%↓ Y/Y)
Total shareholders'
deficit
-$21,299K
(-2039.80%↓ Y/Y)
Common stock, no par
value, 230,000 shares...
$394,945K
(7.33%↑ Y/Y)
Accumulated other
comprehensive income
$67K
(-21.18%↓ Y/Y)
Total liabilities
$50,742K
(2.68%↑ Y/Y)
Contingent consideration
liabilities, noncurrent
$39,541K
(-3.40%↓ Y/Y)
Total current
liabilities
$10,286K
(54.63%↑ Y/Y)
Operating and financing
lease liabilities,...
$915K
Due to related party
(note 9)
$1,979K
Accrued compensation
$1,904K
(30.50%↑ Y/Y)
Accounts payable
$1,871K
(46.52%↑ Y/Y)
Operating and financing
lease liabilities,...
$1,710K
Accrued royalties
$1,116K
(0.00%↑ Y/Y)
Accrued expenses and
other current...
$1,000K
(75.13%↑ Y/Y)
Contingent consideration
liabilities, current
$706K
(2.47%↑ Y/Y)
Back
Back
Balance Sheet
Insight Molecular Diagnostics Inc. (IMDX)
Insight Molecular Diagnostics Inc. (IMDX)
source: myfinsight.com